Martin A. Berliner

Chemistry · Physical Sciences

20h-index1.6kcitations51works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asymmetric Synthesis and Catalysis(14), Synthetic Organic Chemistry Methods(13), Oxidative Organic Chemistry Reactions(10), HER2/EGFR in Cancer Research(7), Chemical Synthesis and Reactions(6)

Publications51 total

Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
2023Open Access
Supplementary Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
2023Open Access
Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
2023Open Access
Supplementary Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
2023Open Access
ChemInform Abstract: Selective Addition of Amines to 5‐Trifluoromethyl‐2,4‐dichloropyrimidine Induced by Lewis Acids.
ChemInform·2013
Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia
Bioorganic & Medicinal Chemistry Letters·2013· 11 citedOpen Access
Selective addition of amines to 5-trifluoromethyl-2,4-dichloropyrimidine induced by Lewis acids
Tetrahedron Letters·2013· 24 cited
Application of A Redox‐Neutral Alcohol Amination in The Kilogram‐Scale Synthesis of A GlyT1 Inhibitor
2013
Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors
Bioorganic & Medicinal Chemistry Letters·2013· 12 citedOpen Access
Multikilogram Synthesis of a Hepatoselective Glucokinase Activator
Organic Process Research & Development·2012· 21 cited
Use of an Iridium-Catalyzed Redox-Neutral Alcohol-Amine Coupling on Kilogram Scale for the Synthesis of a GlyT1 Inhibitor
Organic Process Research & Development·2011· 108 cited
Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus
MedChemComm·2011· 68 cited
Sonogashira Reactions with Propyne: Facile Synthesis of 4-Hydroxy-2-methylbenzofurans from Iodoresorcinols
Organic Process Research & Development·2009· 29 cited
Abstract A86: Design, synthesis, and SAR of focal adhesion kinase (FAK) inhibitors
Molecular Cancer Therapeutics·2009· 2 cited
Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
Cancer Research·2008· 379 citedOpen Access
Route Development and Bulk Synthesis of CP-865,569
Organic Process Research & Development·2007· 13 cited
Nonclinical pharmacological characterization of a focal adhesion kinase inhibitor, PF-562,271
Cancer Research·2007
Synthesis of Alpha‐Halo Ethers from Symmetric Acetals and <i>in Situ</i> Methoxymethylation of an Alcohol
Organic Syntheses·2006· 14 cited
Aqueous Phosphoric Acid as a Mild Reagent for Deprotection of <i>tert</i>-Butyl Carbamates, Esters, and Ethers
The Journal of Organic Chemistry·2006· 97 cited
Potent, selective pyrimidinetrione-based inhibitors of MMP-13
Bioorganic & Medicinal Chemistry Letters·2006· 47 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David R. Williams(12), Michael P. Clark(10), John C. Kath(9), Michael J. Luzzio(8), Nandini C. Patel(8), Susan LaGreca(8), W. Gregory Roberts(7), Ethan Ung(7), Pamela Whalen(7), Catherine A. Hulford(7), Luis Martinez-Alsina(7), Marianne Lorenzen(7), Jitesh P. Jani(7), Eric S. Marr(7), Tarek Sammakia(7), Christofer Autry(6), Earling Emerson(6), Matt Griffor(6), F.F. Vajdos(6), Ulrich Emde(6)